2 Patents
- US117673622023Methods of Treating Cancers Using PD-1 Axis Binding Antagonists and Anti-gpc3 Antibodies
Genentech, Inc.
0 cites - US117608072023Gpc3-targeting Drug Which Is Administered to Patient Responsive to Gpc3-targeting Drug Therapy
F. Hoffmann-la Roche AG
0 cites